Opthea Limited (NASDAQ:OPT - Get Free Report) shares saw strong trading volume on Tuesday . 9,560 shares changed hands during trading, a decline of 53% from the previous session's volume of 20,183 shares.The stock last traded at $3.80 and had previously closed at $3.58.
Analyst Upgrades and Downgrades
Separately, Canaccord Genuity Group upgraded shares of Opthea to a "strong-buy" rating in a report on Tuesday, December 17th.
Check Out Our Latest Report on OPT
Opthea Stock Performance
The stock has a 50-day moving average price of $3.60 and a 200 day moving average price of $3.34.
Institutional Inflows and Outflows
A hedge fund recently bought a new stake in Opthea stock. Twin Lakes Capital Management LLC acquired a new stake in Opthea Limited (NASDAQ:OPT - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 19,806 shares of the company's stock, valued at approximately $81,000. 55.95% of the stock is currently owned by institutional investors and hedge funds.
Opthea Company Profile
(
Get Free Report)
Opthea Limited, a clinical stage biopharmaceutical company, engages in the development and commercialization of therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) VEGF-C, VEGF-D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage.
Read More
Before you consider Opthea, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Opthea wasn't on the list.
While Opthea currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
